BIMINI Biotech
PrivateLast Round
Seed
Jan 8, 2025
Total Funding Raised
$3.89M
Momentum Score
25 /100
Company Overview
BIMINI Biotech is a preclinical stage biotechnology company developing novel first-in-class small molecule therapeutics for oncology with a focus on lymphomas and leukemia.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIMINI Biotech Comps
Public and private peers based on sector, stage, and business model.
BIMINI Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 8, 2025 | ||||
| Seed | Jun 29, 2023 | ||||
| Seed | Oct 15, 2021 | ||||
| Pre Seed | Nov 26, 2020 |
Key People
Founding team and executive leadership
BIMINI Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Libertatis Ergo Holding | Seed |
| Torrey Pines Investment LLC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Dr. Helmuth van Es joins as Independent Supervisory Board Member.
- Jan 8, 2025
$3.1M raised in Seed round.
BIMINI Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BIMINI Biotech's valuation, stock price, and market status.
